ANTH

Anthera Pharmaceuticals, Inc.
ANTH

Overview Fund Activity
Delisted

ANTH was delisted on the 27th of June, 2018.

Back to rankings

40 hedge funds and large institutions have $4.81M invested in Anthera Pharmaceuticals, Inc. in 2017 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 12 increasing their positions, 20 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
40
Holders Change
-20
Holders Change %
-33.33%
% of All Funds
1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
12
Reduced
20
Closed
26
Calls
$585K
Puts
–
Net Calls
+$585K
Net Calls Change
+$675K

Top Buyers

1
SM
Sabby Management
Florida
+$604K
2
Millennium Management
Millennium Management
New York
+$234K
3
ECM
Element Capital Management
New York
+$70K
4
PP
Paloma Partners
Connecticut
+$60K
5
WS
Wedbush Securities
California
+$52.1K

Top Sellers

1
Franklin Resources
Franklin Resources
California
-$1.36M
2
BlackRock
BlackRock
New York
-$479K
3
State Street
State Street
Massachusetts
-$287K
4
SCM
Sio Capital Management
New York
-$142K
5
SG Americas Securities
SG Americas Securities
New York
-$98K
Name Holding Trade Value Shares
Change 		Shares
Change %
GC
51
Guggenheim Capital
Illinois
– -$6K -1,893 Closed
BIA
52
Barry Investment Advisors
Massachusetts
– -$6K -1,875 Closed
MCC
53
Malaga Cove Capital
California
– -$5K -1,500 Closed
Citadel Advisors
54
Citadel Advisors
Florida
– -$5K -1,498 Closed
Legal & General Group
55
Legal & General Group
United Kingdom
– -$5K -1,458 Closed
AIP
56
Ameritas Investment Partners
Nebraska
– -$1K -346 Closed
1 2
3